Endothelial cell proliferation is required for angiogenesis in both embryonic and adult tissues. In rat brain tumors, it has recently been shown that the nuclear protein pigpen is expressed selectively in endothelial cells of developing microvasculature but not in the established peritumoral vessels (Blank, M., Weinschenk, T., Priemer, M., and Schluesener, H. (2001) J. Biol. Chem. 276, 16464 -16468). This finding suggests that pigpen may be important for promoting the undifferentiated, or "angiogenic" endothelial cell phenotype. Our studies show that pigpen protein and mRNA are expressed in actively dividing endothelial cells and down-regulated as they become confluent. Protein distribution is regulated in a cell cycle-dependent manner. We conclude that this expression pattern is important for and not simply ancillary to proliferation because nuclear microinjection of anti-pigpen Fab fragments inhibited endothelial cell division. Moreover, expression of the proliferating cell marker Ki67 was inhibited in antibody-injected cells. The absence of Ki67 suggests exit from rather than arrest within (for example, at the G 1 /S interface) the cell cycle. Together with earlier observations on the structure and expression of this molecule, our data support the hypothesis that pigpen helps regulate endothelial cell differentiation state.Angiogenesis is the development of new blood vessels from existing vasculature. It begins early and continues throughout embryonic development, extending early rudiments of the vascular system to meet the nutritive requirements of growing tissues. In adult tissues angiogenesis is a relatively rare and tightly regulated event. Endothelial cells (EC) 1 must therefore be transformed from a quiescent, non-proliferative state to an undifferentiated/proliferative phenotype that provides the building blocks and framework for new vessels. This process occurs normally during wound healing and cyclic reproductive events but can also be triggered by a variety of pathological conditions resulting in considerable tissue damage (1). New blood vessel development is critical for tumor growth and metastasis, for example. In the eye, angiogenesis is involved in more than 20 disorders (2), including neovascular glaucoma, age-related macular degeneration, and proliferative diabetic retinopathy.Great progress has been made in our understanding of extracellular factors governing angiogenesis. Control of EC phenotype is generally thought to be regulated by a balance of stimulators and inhibitors. We have a great deal more to learn about the downstream effectors of angiogenesis, however, especially the nuclear factors that convert incoming signals into the new genetic program. Induction of several well known nuclear regulatory molecules has been shown to accompany angiogenic stimulation. For example, analogues of the immediate early genes, c-fos, c-jun, and egr-1 are induced in phorbol 12-myristate 13-acetate-stimulated EC (3). Phorbol 12-myristate 13-acetate also induces EDG-2, a human homologue of the Xenopus G1...